Primary experimental recordPositive observation

PMC12935919::ACT037547

Myoki

Evidence text

Paper-level observation

Section 3.2 / Figure 3A: 'On Day 6, Western blot analysis of the 100 μM Myoki treated group showed that the expression levels of alpha-actinin and MYH3 significantly increased by 818% and 307%, respectively.'

textConfidence: medium

Assay observation

Activity

Metabolic/Cardiovascular

Subtype

Other

Measure

fold_change

Comparator

Raw observation

307%

Normalized measurement

=307%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Mus musculus

Assay method

Not reported by source

Sequence

EAEYEHL

Standardization

ready simple

Source publication

The therapeutic potential of Myoki, a novel peptide in muscle atrophy: mechanisms and applications.

Frontiers in Pharmacology · 2026

DOI 10.3389/fphar.2026.1663850 PMC12935919

Parent mention

Related peptide identities

PEPDIA-PLP-000522

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.